Literature DB >> 6832798

Disease associations with complotypes, supratypes and haplotypes.

R L Dawkins, F T Christiansen, P H Kay, M Garlepp, J McCluskey, P N Hollingsworth, P J Zilko.   

Abstract

We have used the term supratype to describe combinations of alleles and have examined associations with disease. In RA and insulin-dependent diabetes one or more supratypes appear to be important but their functional significance remains obscure. In MG and SLE the HLA supratype may contain loci involved in immunoregulation, complement synthesis and hormone metabolism. MG induced by D-Pen is associated with Bw35/DR1 rather than A1, B8, DR3. In contrast there is no evidence of a supratype in AS. We have proposed a model for the pathogenesis of sacroiliitis and AS and have postulated two non-linked genes which act stepwise upon HLA-B27. There are cogent reasons for examining the functional effects of known loci within the MHC and particularly those involved in the expression of complement components.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6832798     DOI: 10.1111/j.1600-065x.1983.tb00707.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  57 in total

Review 1.  The immunogenetics of rheumatoid arthritis.

Authors:  B P Wordsworth; J I Bell
Journal:  Springer Semin Immunopathol       Date:  1992

2.  A continuous restriction map from HLA-E to HLA-F. Structural comparison between different HLA-A haplotypes.

Authors:  A el Kahloun; C Vernet; A M Jouanolle; J Boretto; V Mauvieux; J Y Le Gall; V David; P Pontarotti
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

3.  Circulating immune complexes and complement C4 null alleles in patients in patients operated on for premature atherosclerotic peripheral vascular disease.

Authors:  S Nityanand; L Truedsson; A Mustafa; C Bergmark; A K Lefvert
Journal:  J Clin Immunol       Date:  1999-11       Impact factor: 8.317

4.  Pleiotropic effects of the 8.1 HLA haplotype in patients with autoimmune myasthenia gravis and thymus hyperplasia.

Authors:  Claire Vandiedonck; Geneviève Beaurain; Matthieu Giraud; Catherine Hue-Beauvais; Bruno Eymard; Christine Tranchant; Philippe Gajdos; Jean Dausset; Henri-Jean Garchon
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-15       Impact factor: 11.205

5.  The genomic structure of two ancestral haplotypes carrying C4A duplications.

Authors:  K Tokunaga; W J Zhang; F T Christiansen; R L Dawkins
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

6.  Ek alpha transgene in B10 mice suppresses the development of myasthenia gravis.

Authors:  P Christadoss; C S David; M Shenoy; S Keve
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

7.  Association of HLA-Bw46DR9 combination with juvenile myasthenia gravis in Chinese.

Authors:  W H Chen; H C Chiu; R P Hseih
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-04       Impact factor: 10.154

8.  Factors governing the human immune response to injected insulin.

Authors:  W G Reeves; D Barr; C A Douglas; K Gelsthorpe; I Hanning; A Skene; L Wells; R M Wilson; R B Tattersall
Journal:  Diabetologia       Date:  1984-04       Impact factor: 10.122

9.  Anonymous marker loci within 400 kb of HLA-A generate haplotypes in linkage disequilibrium with the hemochromatosis gene (HFE)

Authors:  J Yaouanq; M Perichon; M Chorney; P Pontarotti; A Le Treut; A el Kahloun; V Mauvieux; M Blayau; A M Jouanolle; B Chauvel
Journal:  Am J Hum Genet       Date:  1994-02       Impact factor: 11.025

10.  Ancestral haplotypes reveal the role of the central MHC in the immunogenetics of IDDM.

Authors:  M A Degli-Esposti; L J Abraham; V McCann; T Spies; F T Christiansen; R L Dawkins
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.